Therapeutic Index for Local Infections score validity: a retrospective European analysis.


Journal

Journal of wound care
ISSN: 0969-0700
Titre abrégé: J Wound Care
Pays: England
ID NLM: 9417080

Informations de publication

Date de publication:
02 Dec 2020
Historique:
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 2 7 2021
Statut: ppublish

Résumé

A score to identify local wound infections was developed by a panel of experts from seven European countries. The Therapeutic Index for Local Infections (TILI) score was designed for health professionals who are not specialised in wound care. This study was carried out to test the validity of the TILI score in everyday practice. Content validity was analysed by means of evaluation by a panel of experts, individually and face-to-face, followed by a European multicentred, retrospective, observational study. Participating clinicians sent anonymised copies of completed TILI scores for patients with leg ulcers along with a photograph of the wound for analysis by two blinded reviewers. Concordance (Kappa index) and convergent criterion validity (sensitivity, specificity, accuracy, Youden's J Index and receiver operator characteristic (ROC) or area under the curve (AUC) curve) were calculated to construct validity and reliability. A total of 307 patients with leg ulcers from seven institutions in five European countries were included in this retrospective analysis. It was shown that the diagnosis of local wound infection could be documented well with five of the six clinical criteria included in the TILI score. By summing up these facultative criteria in comparison with any direct criteria that may be present, there would have been an indication for local antiseptic wound therapy in 22% of patients examined. The results show that the TILI score is concordant with the expert assessment of patients and with good diagnostic characteristics. Thus, the easy-to-use TILI score can now be used in the daily routine practice of health professionals to diagnose local wound infections.

Identifiants

pubmed: 33320752
doi: 10.12968/jowc.2020.29.12.726
doi:

Substances chimiques

Anti-Infective Agents, Local 0

Types de publication

Journal Article Observational Study

Langues

eng

Pagination

726-734

Auteurs

Joachim Dissemond (J)

Department for Dermatology, Venerology and Allergology, University School of Medicine, Essen, Germany.

Robert Strohal (R)

Department of Dermatology and Venerology, Federal Academic Teaching Hospital, Feldkirch, Austria.

Diego Mastronicola (D)

Outpatient Wound Care Centre, Local Health Care System Frosinone, Frosinone, Italy.

Eric Senneville (E)

Department of Infectious Diseases, Tourcoing Hospital, France.

Cécile Moisan (C)

Department of Vascular and Endocrinology Surgery, Hopital Yves Le Foll St-Brieuc, France.

Valerie Edward-Jones (V)

Department of Medical Microbiology, Manchester Metropolitan University, UK.

Kirsty Mahoney (K)

Department of Wound Healing, Welsh Wounds Innovation centre, Primary, Community and Intermediate Care Division, Rhondda Cynon Taf, UK.

Adam Junka (A)

Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, Poland.

Marzenna Bartoszewicz (M)

Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, Poland.

José Verdú-Soriano (J)

Department of Community Nursing, Preventive Medicine, Public Health and History of Science, Faculty of Health Sciences, University of Alicante, Alicante, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH